Han-xi Ding
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Research and Splicing
- Extracellular vesicles in disease
Papers in
-
- Cancer-related molecular mechanisms research 11
- MicroRNA in disease regulation 3
- Cancer Genomics and Diagnostics 1
-
- Circular RNAs in diseases 6
- RNA modifications and cancer 5
- Co-authors
- Zhi Gang Lv (12 shared papers)Yuan Yuan (13 shared papers)Qian Xu (11 shared papers)Xinxin Fang (4 shared papers)Qian Xu (3 shared papers)Jing Wen (2 shared papers)Shixuan Shen (4 shared papers)Yuan Yuan (1 shared paper)
- Journals
- Bioscience Reports (5 papers)Frontiers in Oncology (3 papers)Future Oncology (2 papers)ACS Biomaterials Science & Engineering (1 paper)Gene (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Han-xi Ding
22 papers receiving 311 citations
Peers
Comparison fields: 5 of 42
- Cancer Research 203
- Molecular Biology 204
- Oncology 28
- Immunology 16
- Pulmonary and Respiratory Medicine 22
Countries citing papers authored by Han-xi Ding
This map shows the geographic impact of Han-xi Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Han-xi Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Han-xi Ding more than expected).
Fields of papers citing papers by Han-xi Ding
This network shows the impact of papers produced by Han-xi Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Han-xi Ding. The network helps show where Han-xi Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Han-xi Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 41 | |
| 2 | 2018 | 36 | |
| 3 | 2018 | 29 | |
| 4 | 2017 | 28 | |
| 5 | 2019 | 25 | |
| 6 | 2018 | 22 | |
| 7 | 2019 | 16 | |
| 8 | 2021 | 16 | |
| 9 | 2023 | 15 | |
| 10 | 2022 | 15 | |
| 11 | 2020 | 14 | |
| 12 | 2020 | 11 | |
| 13 | 2021 | 11 | |
| 14 | 2021 | 11 | |
| 15 | 2018 | 7 | |
| 16 | 2018 | 7 | |
| 17 | 2020 | 5 | |
| 18 | 2021 | 3 | |
| 19 | 2020 | 2 | |
| 20 | 2023 | 1 |
About Han-xi Ding
Han-xi Ding is a scholar working on Cancer Research, Molecular Biology, Oncology, Endocrinology, Diabetes and Metabolism and Infectious Diseases, having authored 22 papers that have together received 317 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (11 papers), Circular RNAs in diseases (6 papers), RNA modifications and cancer (5 papers), Helicobacter pylori-related gastroenterology studies (3 papers), MicroRNA in disease regulation (3 papers), Mycobacterium research and diagnosis (2 papers), Cancer Genomics and Diagnostics (1 paper) and CAR-T cell therapy research (1 paper). The work is most often cited by research in Cancer Research (203 citations), Molecular Biology (204 citations), Oncology (28 citations), Immunology (16 citations) and Pulmonary and Respiratory Medicine (22 citations). Han-xi Ding has collaborated with scholars based in China and United States. Frequent co-authors include Zhi Gang Lv, Yuan Yuan, Qian Xu, Xinxin Fang, Qian Xu, Jing Wen, Shixuan Shen, Yuan Yuan, Rong Wu and Mingjun Sun. Their work appears in journals such as Bioscience Reports, Frontiers in Oncology, Future Oncology, ACS Biomaterials Science & Engineering and Gene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.